Aqr Capital Management LLC Aclaris Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.01 - $1.36 $228,288 - $307,398	-226,028 Reduced 36.92%	386,177 $424,000
Q1 2024 May 15, 2024	BUY	$0.92 - $1.44 $563,228 - $881,575	612,205 New	612,205 $759,000
Q1 2023 May 15, 2023	BUY	$7.07 - $17.95 $39,818 - $101,094	5,632 Added 39.29%	19,968 $161,000
Q4 2022 Feb 14, 2023	BUY	$14.33 - $18.37 $45,483 - $58,306	3,174 Added 28.44%	14,336 $225,000
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $5,358 - $7,470	410 Added 3.81%	11,162 $176,000
Q2 2022 Aug 15, 2022	SELL	$10.16 - $17.08 $650 - $1,093	-64 Reduced 0.59%	10,752 $150,000
Q1 2022 May 16, 2022	SELL	$9.74 - $17.92 $88,819 - $163,412	-9,119 Reduced 45.74%	10,816 $186,000
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.49 $487,867 - $735,180	-39,761 Reduced 66.61%	19,935 $290,000
Q3 2021 Nov 15, 2021	BUY	$13.38 - $18.8 $393,813 - $553,340	29,433 Added 97.26%	59,696 $1.08 Million
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $516,892 - $895,784	30,263 New	30,263 $531,000
Q4 2017 Feb 14, 2018	SELL	$21.47 - $27.8 $228,118 - $295,375	-10,625 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $244,587 - $306,000	10,625	10,625 $274,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.